There are 5 trials going on now. 2 with melanoma, 2 with fibrosis/cirrhosis and 1 with psoriasis. We should have news first on the psoriasis trial, I'd guess early next year, then on the short term cirrhosis trial around the same time frame. The longer term trial won't be till mid 2017. I have no idea when we'll hear anything on the melanoma trials. These are my best guesses based on what I remember mgmt saying during the most recent presentations.
Hopefully the psoriasis trial goes well. That would be the one I'd think they'd be most open to selling to a big pharma. It's estimated to have a 15 B. market size and since there are no known side effects it'd be a prime replacement for most of the current therapies. If we could get up front $$$ plus a sales percentage and have the pharma complete the trial, that could fund the other trials through completion of at least the PII trials.
These are the hopes and prayers I have, but have more often than not been disappointed.
News 
Market Data 
Discover 
